Efficacy of Nirmatrelvir/Ritonavir (Paxlovid) for COVID-19 in Vaccinated Patients With Inflammatory Bowel Disease
Mikhail et al., American Journal of Gastroenterology, doi:10.14309/01.ajg.0001082744.48729.45
https://c19early.org/mikhail.html